Cargando…

Canada’s provinces and territories should disclose cannabis data to support research

Detalles Bibliográficos
Autor principal:	Armstrong, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Joule Inc. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034318/ https://www.ncbi.nlm.nih.gov/pubmed/33685953 http://dx.doi.org/10.1503/cmaj.202041

Ejemplares similares

Improving the regulation of medical cannabis in Canada to better serve pediatric patients
por: Huntsman, Richard J., et al.
Publicado: (2021)

Initial indicators of the public health impacts of non-medical cannabis legalization in Canada
por: Fischer, Benedikt, et al.
Publicado: (2020)

Les provinces et territoires du Canada devraient publier des données sur le cannabis pour soutenir la recherche
por: Armstrong, Michael J.
Publicado: (2021)

Multimorbidity prevalence in Canada: a comparison of Northern Territories with Provinces, 2013/14
por: Basham, C. Andrew, et al.
Publicado: (2019)

“Where does the high road lead?” Potential implications of cannabis legalization for pediatric injuries in Canada
por: Karbakhsh, Mojgan, et al.
Publicado: (2018)

Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark
por: Fischer, Benedikt, et al.
Publicado: (2023)

Supporting peer researchers: recommendations from our lived experience/expertise in community-based research in Canada
por: Ibáñez-Carrasco, Francisco, et al.
Publicado: (2019)

Real World Evidence in Medical Cannabis Research
por: Banerjee, Rishi, et al.
Publicado: (2021)

Developing territory for active learning
por: Marder, Michael
Publicado: (2022)

Connections between health research systems and decision-making spaces: lessons from the COVID-19 pandemic in the province of Québec, Canada
por: Smits, Pernelle, et al.
Publicado: (2023)

The balancing act of disclosing outbreaks of SARS-CoV-2 in workplaces
por: Tran, Maxwell, et al.
Publicado: (2021)

Professionals do not invite children to disclose family problems: A comment
por: Näsman, Elisabet
Publicado: (2019)

Vaccine Impact Data Should Support Country Decision Making
por: Nelson, E Anthony S, et al.
Publicado: (2017)

The Devil Is in the Details! On Regulating Cannabis Use in Canada Based on Public Health Criteria: Comment on "Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts"
por: Rehm, Jürgen, et al.
Publicado: (2016)

HIV recency testing: should results be disclosed to individuals tested?
por: Abdool Karim, Quarraisha, et al.
Publicado: (2020)

Canada Should Move Toward Adopting Harmonized Evidence-Based OELs to Consistently and Adequately Protect Workers
por: Barn, Prabjit, et al.
Publicado: (2020)

Why a distinct medical stream is necessary to support patients using cannabis for medical purposes
por: Costiniuk, Cecilia, et al.
Publicado: (2023)

Prehospital advanced trauma life support: how should we manage the airway, and who should do it?
por: Brambrink, Ansgar M, et al.
Publicado: (2004)

Should research be part of advance care planning?
por: Easson, Alexandra M
Publicado: (2005)

Should Physicians Disclose Their Own Health Challenges? Perspectives of Patients With Chronic Pain
por: Chang, Howard A, et al.
Publicado: (2022)

Transforming race-based health research in Canada
por: Datta, Geetanjali, et al.
Publicado: (2021)

Patients with kidney failure who cannot access dialysis in rural and remote areas of Canada should be prioritized for kidney transplantation
por: Trachtenberg, Aaron J., et al.
Publicado: (2021)

Disparities in telehealth use: How should the supportive care community respond?
por: Dixit, Niharika, et al.
Publicado: (2021)

Research publications: Should they be mandatory for promotions of medical teachers?
por: Sukhlecha, Anupama
Publicado: (2011)

Prisoners should not be left behind in HCV research and policies
por: Moazen, Babak, et al.
Publicado: (2020)

To disclose, or not to disclose? Context matters
por: Rahimzadeh, Vasiliki, et al.
Publicado: (2015)

21st century headache: mapping new territory
por: Goadsby, Peter J., et al.
Publicado: (2021)

New Zealand's failed cannabis legalization referendum – implications for cannabis policy reform
por: Fischer, Benedikt, et al.
Publicado: (2021)

Should infectious disease modelling research be subject to ethics review?
por: Green, Ben
Publicado: (2023)

Vaccine safety concerns: Should we be changing the way we support immunization?
por: MacDonald, Noni E, et al.
Publicado: (2020)

Prescribing cannabis for harm reduction
por: Collen, Mark
Publicado: (2012)

The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand
por: Fischer, Benedikt, et al.
Publicado: (2020)

The commercialization of patient data in Canada: ethics, privacy and policy
por: Spithoff, Sheryl, et al.
Publicado: (2022)

The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017–2022
por: Hallinan, Christine Mary, et al.
Publicado: (2022)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

Research agenda in family medicine—should we adopt the Dutch approach?
por: Vinker, Shlomo, et al.
Publicado: (2019)

Unintentional Pediatric Cannabis Exposures After Legalization of Recreational Cannabis in Canada
por: Myran, Daniel T., et al.
Publicado: (2022)

Why you should share your data during a pandemic
por: Smith, Emily R, et al.
Publicado: (2021)

"ATR activation in response to ionizing radiation: still ATM territory"
por: Cuadrado, Myriam, et al.
Publicado: (2006)

Attempt to assess Canada’s expertise in global health research falls short
por: Gyorkos, Theresa W.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ijrbjb40big9ure4doo8dmc0v8